2 min read

Oracle Adds To Its Health Sciences Portfolio

The database giant is acquiring the intellectual property of Conformia, maker of software used in the production of chemical, biotechnology, and pharmaceutical products.
Oracle Wednesday acquired the intellectual property assets of Conformia Software, a supplier of product life-cycle management software for manufacturers producing in highly regulated industries. No price was disclosed in the acquisition.

Its software found adoption in the life sciences community involved in the production of chemical, biotechnology, and pharmaceutical products.

Oracle will integrate the Sunnyvale, Calif., company's product line into its Oracle Health Sciences applications and third-party systems, company officials said. It will also integrate its technology in Oracle Agile Product Lifecycle Management as an application that covers drug development, packaging, and commercialization.

"The addition of Conformia Software technology underscores Oracle's commitment to provide customers with a differentiated, out-of-the-box, industry-based solution," said Hardeep Gulati, Oracle's VP of product life-cycle management strategy. The Conformia acquisition "will give our life sciences industry customers a complete solution to manage the entire pharmaceutical and biotechnology production and distribution life cycle," he added.

Oracle also already offers Oracle for Healthcare applications for the healthcare business, the company said.

Conformia was founded in 2000 in Redwood City, Calif., as RIVA Commerce. By 2005, it had offices there and in Bangalore, India, as well, before moving its headquarters to Sunnyvale.

Its venture capital backers include: Sequoia Capital, Mentor Capital Group, and Foundation Capital. The company has raised an estimated total of $23 million in private funding. Revenue in 2007 was reported as $11.5 million.

InformationWeek has published an in-depth report on server virtualization. Download the report here (registration required).